Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy plus paclitaxel polymer micelles and platinum for locally advanced solid tumors
ChiCTR2300071667Phase 2Not yet recruiting
- Sponsor
- Beidahuang Group General Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in Nonhematologic neoplasms, sponsored by Beidahuang Group General Hospital. Primary endpoint: Objective response rate. Planned start May 2023; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR2300071667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071667.